Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Medical Care|June 19, 2009
Design and analysis issues for economic analysis alongside clinical trialsDeborah A Marshall, Margaret HuxCanadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|October 25, 2007
Cost-effectiveness of memantine compared with standard care in moderate-to-severe Alzheimer disease in CanadaMicheline Gagnon, Benoît Rive, Margaret Hux, et al.Ostomy/Wound Management|December 4, 2003
Cost-effectiveness of becaplermin for nonhealing neuropathic diabetic foot ulcersR Gary Sibbald, George Torrance, Margaret Hux, et al.The Canadian Journal of Urology|September 24, 2004
An economic evaluation of doxazosin, finasteride and combination therapy in the treatment of benign prostatic hyperplasiaHeather McDonald, Margaret Hux, Marc Brisson, et al.Journal of Drugs in Dermatology : JDD|March 22, 2007
Cost-effectiveness of a fixed combination of hydroquinone/tretinoin/fluocinolone cream compared with hydroquinone alone in the treatment of melasmaTania Cestari, Lucie Adjadj, Margaret Hux, et al.International Journal of Technology Assessment in Health Care|July 17, 2003
Health care resource use and stroke outcome. Multinational comparisons within the GAIN International trialKjell Asplund, Sharron Ashburner, Kathy Cargill, et al.American Journal of Obstetrics and Gynecology|May 16, 2002
The burden of illness of severe nausea and vomiting of pregnancy in the United StatesCheryl L Attard, Michele A Kohli, Suzanne Coleman, et al.Journal of Health Economics and Outcomes Research|September 4, 2023
A Cost-effectiveness Analysis of Brentuximab Vedotin in Relapsed or Refractory Systemic Anaplastic Large Cell LymphomaMargaret Hux, Denise Zou, Esprit Ma, et al.Chest|August 9, 2003
An economic evaluation of sequential i.v./po moxifloxacin therapy compared to i.v./po co-amoxiclav with or without clarithromycin in the treatment of community-acquired pneumoniaMichael F Drummond, Debbie L Becker, Margaret Hux, et al.Influenza and Other Respiratory Viruses|November 11, 2017
Resource utilization and cost of influenza requiring hospitalization in Canadian adults: A study from the serious outcomes surveillance network of the Canadian Immunization Research NetworkCarita Ng, Lingyun Ye, Stephen G Noorduyn, et al.Pageof 1